Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Anesthetic Agents >  Skeletal muscle relaxants >  Afloqualone

Afloqualone

Basic information Safety Supplier Related

Afloqualone Basic information

Product Name:
Afloqualone
Synonyms:
  • Afloqualone 6-Amino-2-(fluoromethyl)-3-(2-methylphenyl)-quinazolin-4-one
  • 6-Amino-2-fluoromethyl-3-(o-tolyl)-quinazolin-4(3H)-one
  • H-495
  • HQ 495
  • HQ-495
  • Afloquanone
  • 6-aMino-2-fluoroMethyl-3-(o-tolyl)-4(3h)-quinaz...
  • 6-amino-2-(fluoromethyl)-3-(2-methylphenyl)-4(3h)-quinazolinon
CAS:
56287-74-2
MF:
C16H14FN3O
MW:
283.3
EINECS:
1592732-453-0
Product Categories:
  • API
  • Other APIs
Mol File:
56287-74-2.mol
More
Less

Afloqualone Chemical Properties

Melting point:
195-196°C
Boiling point:
492.5±55.0 °C(Predicted)
Density 
1.2529 (estimate)
storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
solubility 
DMSO (Slightly), Methanol (Slightly)
form 
Solid
pka
2.73±0.70(Predicted)
color 
White to Off-White
InChI
InChI=1S/C16H14FN3O/c1-10-4-2-3-5-14(10)20-15(9-17)19-13-7-6-11(18)8-12(13)16(20)21/h2-8H,9,18H2,1H3
InChIKey
VDOSWXIDETXFET-UHFFFAOYSA-N
SMILES
N1C2=C(C=C(N)C=C2)C(=O)N(C2=CC=CC=C2C)C=1CF
CAS DataBase Reference
56287-74-2(CAS DataBase Reference)
More
Less

Safety Information

Toxicity
LD50 in mice (mg/kg): 315.1 i.p. (Tani)
More
Less

Afloqualone Usage And Synthesis

Description

Afloqualone is a centrally acting muscle relaxant useful in the management of various spastic conditions, including cerebral palsy, cervical spondylosis, and multiple sclerosis. It is closely related to the hypnotidsedative methaqualone.

Description

Afloqualone (Item No. 21834) is an analytical reference standard categorized as a quinazolinone. This product is intended for research and forensic applications.

Originator

Tanabe (Japan)

Uses

Afloqualone acts as a muscle relaxant in humans and may be used in the treatment of muscle spasms affecting rheumatoid arthritis.

Definition

ChEBI: Afloqualone is an organic molecular entity.

Manufacturing Process

14.4 g (0.053 mol) of N-(2-amino-5-nitrobenzoyl)-o-toluidine and 6.3 g (0.08 mol) of pyridine are dissolved in 300 ml of tetrahydrofuran. 12.2 g (0.126 mol) of fluoroacetyl chloride are added to the solution for 10 minutes under ice-cooling. The solution is stirred at the same temperature for 30 minutes and then at room temperature for 2.5 hours. The reaction solution is allowed to stand at room temperature overnight. The crystalline precipitate is collected by filtration, washed with water and then dried. 16.4 g of N-(2- fluoroacetamido-5-nitrobenzoyl)-o-toluidine are obtained. Yield: 93.7%; MP 238-239°C.
16.5 g (0.05 mol) of N-(2-fluoroacetamido-5-nitrobenzoyl)-o-toluidine and 25.5 g (0.25 mol) of acetic acid anhydride are dissolved in 250 ml of glacial acetic acid. The solution is refluxed for 2 hours under heating. Then, the reaction solution is evaporated to remove solvent. The residue thus obtained is poured into ice-water, and the aqueous mixture is adjusted to pH 9 with potassium carbonate. The crystalline precipitate is collected by filtration. 15.5 g of 2-fluoromethyl-3-(o-tolyl)-6-nitro-4(3H)-quinazolinone are obtained. Yield: 98.7%; MP 155-158°C (recrystallized from ethanol).
A mixture of 2.0 g (0.064 mol) of 2-fluoromethyl-3-(o-tolyl)-6-nitro-4(3H)- quinazolinone, 0.2 g of 5% palladium-carbon and 100 ml of acetic acid is shaken for 30 minutes in hydrogen gas. The initial pressure of hydrogen gas is adjusted to 46 lb and the mixture is heated with an infrared lamp during the reaction. After 30 minutes of this reaction, the pressure of hydrogen gas decreases to 6 lb. After the mixture is cooled, the mixture is filtered to remove the catalyst. The filtrate is evaporated to remove acetic acid, and the residue is dissolved in chloroform. The chloroform solution is washed with 5% aqueous sodium hydroxide and water, successively. Then, the solution is dried and evaporated to remove solvent. The oily residue thus obtained is dissolved in 2 ml of chloroform, and the chloroform solution is passed through a column of 200 g of silica gel. The silica gel column is eluted with ethyl acetatebenzene (1:1). Then, the eluate is evaporated to remove solvent. The crude crystal obtained is washed with isopropyl ether and recrystallized from isopropanol. 0.95 g of 2-fluoromethyl-3-(o-tolyl)-6-amino-4(3H)-quinazolinone is obtained. Yield: 52.5%; MP 195-196°C.

brand name

AROFUTO

Therapeutic Function

Muscle relaxant

AfloqualoneSupplier

JinYan Chemicals(ShangHai) Co.,Ltd.
Tel
13817811078
Email
sales@jingyan-chemical.com
LGM Pharma
Tel
1-(800)-881-8210
Email
inquiries@lgmpharma.com
Shanghai Ennopharm Co., Ltd.
Tel
+86 (21) 6435-5022
Hangzhou Yuhao Chemical Technology Co., Ltd
Tel
0571-82693216
Email
info@yuhaochemical.com
Wisdom Pharmaceutical Co., Ltd.
Tel
0086-15189180296
Email
l_xu@wisdompharma.com